Aura Biosciences, Inc. (AURA:NASDAQ) closed at $6.30 on October 23, 2026, down 2.48% on the day. The stock trades 33.9% below its 52-week high of $9.54 and 33.2% above its 52-week low of $4.73. Over the past year, it gained 7.5%. Aura Biosciences, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, AURA closed higher on 112 days (44%). Its best day was May 4, 2026 (+19.12%) and its worst was July 6, 2026 (-8.40%). The stock moved 10% or more in a single session 5 times.
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity.
Find more stocks like AURA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.